25021-128 : Ceftazidime 2 g/1 Intravenous Injection, Powder, for Solution
NDC: | 25021-128 |
Labeler: | Sagent Pharmaceuticals |
Product Type: | Human Prescription Drug |
Drug Name: | Ceftazidime |
Dosage Form: | Intravenous Injection, Powder, for Solution |
Application #: | ANDA062640 |
Rev. Date: |
NDC Package Codes:
- 25021-128-50: 10 VIAL IN 1 CARTON (25021‑128‑50) > 1 INJECTION, POWDER, FOR SOLUTION IN 1 VIAL
- 25021-128-67: 10 VIAL IN 1 CARTON (25021‑128‑67) > 2 INJECTION, POWDER, FOR SOLUTION IN 1 VIAL
Active Ingredients:
- Ceftazidime
Dosage Strength:
- 2 g/1
Pharmaceutical Classes:
- Cephalosporin Antibacterial [EPC]
- Cephalosporins [CS]
Related Products:
Based on records with the same trade name.- 25021-127 Ceftazidime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals
- 25021-129 Ceftazidime 6 g/30ml Intravenous Injection, Powder, for Solution by Sagent Pharmaceuticals
- 0781-3177 Ceftazidime 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Sandoz Inc
- 0781-3178 Ceftazidime 2 g/1 Intravenous Injection, Powder, for Solution by Sandoz Inc
- 0781-3179 Ceftazidime 200 mg/ml Intravenous Injection, Powder, for Solution by Sandoz Inc
- 44567-235 Ceftazidime 1 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
- 44567-236 Ceftazidime 2 g/20ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
- 44567-237 Ceftazidime 6 g/100ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 25021-127Next: 25021-129 >
Related Discussions:
CEFTAZIDIME PRODUCT MONOGRAPH
PLEASE CEFTAZIDIME complete information as early as possible. ## Ceftazidime is usually reserved for the treatment of in... 1 reply
PLEASE CEFTAZIDIME complete information as early as possible. ## Ceftazidime is usually reserved for the treatment of in... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.